The U.S. PRP and stem cell alopecia treatment market size is expected to reach USD 183.3 million by 2025 at a 5.1% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Factors contributing to the growth of this market include rise in disease awareness, increased treatment rate, and growing adoption of novel treatment therapies providing positive patient outcome. Moreover, lower incidences of negative side effects due to this therapy is anticipated to fuel demand for platelet rich plasma (PRP) and stem cell therapy.
Adoption of PRP and stem cell therapy for alopecia is expected to increase owing to rise in number of patients preferring novel therapies over conventional therapies. In addition to this, shorter treatment duration, faster hair regrowth, and improved patient outcome are expected to drive demand for these therapies over the forecast period.
By treatment type, PRP procedures accounted for the largest share of 58.1% in 2017 in terms of procedural volume. However, owing to lower prices of PRP procedures, stem cell therapy procedures accounted for the dominant revenue share in 2017, valued at USD 70.1 million. By end use, the dermatology clinics segment accounted for 85.0% of the total market revenue in 2017, owing to its lower therapy cost as compared to hospitals.
The competitive landscape includes clinics such as Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, PLC, NovaGenix, Virginia Surgical Center, and Hair Transplant Institute of Miami.
Full Research Report On U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market Analysis: www.grandviewresearch.com/industry-analysis/us-platelet-rich-plasma-prp-stem-cell-alopecia-treatment-market
Further key findings from the report suggest:
Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the U.S. PRP and stem cell alopecia treatment market on the basis of treatment and end user:
U.S. PRP and Stem Cell Alopecia Treatment Outlook (Procedures; Revenue, USD Million, 2013 – 2025)
U.S. PRP and Stem Cell Alopecia Treatment End User (Procedures; Revenue, USD Million, 2013 – 2025)
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:28 2nd Street, Suite 3036 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: www.grandviewresearch.com/industry-analysis/us-platelet-rich-plasma-prp-stem-cell-alopecia-treatment-market